Design of more potent quinazoline derivatives as EGFRWT inhibitors for the treatment of NSCLC: a computational approach
Abstract Background Lung cancer remains the leading and deadly type of cancer worldwide. It was estimated to account for about 25% of the 7 million people that died as a result of cancer-related issues/mortality every year in the world. Non-small cell lung cancer (NSCLC) is the lethal/deadly class o...
Main Authors: | Muhammad Tukur Ibrahim, Adamu Uzairu, Sani Uba, Gideon Adamu Shallangwa |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2021-07-01
|
Series: | Future Journal of Pharmaceutical Sciences |
Subjects: | |
Online Access: | https://doi.org/10.1186/s43094-021-00279-3 |
Similar Items
-
Computer-aided molecular modeling studies of some 2, 3-dihydro-[1, 4] dioxino [2, 3-f] quinazoline derivatives as EGFRWT inhibitors
by: Muhammad Tukur Ibrahim, et al.
Published: (2020-04-01) -
Computational modeling of novel quinazoline derivatives as potent epidermal growth factor receptor inhibitors
by: Muhammad Tukur Ibrahim, et al.
Published: (2020-02-01) -
Structure-based design of some quinazoline derivatives as epidermal growth factor receptor inhibitors
by: Muhammad Tukur Ibrahim, et al.
Published: (2020-11-01) -
Computational virtual screening and structure-based design of some epidermal growth factor receptor inhibitors
by: Muhammad Tukur Ibrahim, et al.
Published: (2020-08-01) -
Computer-aided design of some quinazoline analogues as epidermal growth factor receptor inhibitors
by: Muhammad Tukur Ibrahim, et al.
Published: (2021-06-01)